Category

Advertisement

Clinical Trials

First gastroesophageal cancer patients enrolled in Affibody’s Phase 2 basket trial

April 4, 2024

Affibody has announced that the …

Sobi announces positive Phase 3 results

March 26, 2024

Sobi has announced results from …

Michael Engsig

Nykode announces updated Phase 2 data

March 21, 2024

Nykode Therapeutics has announced key …

Göran Forsberg Photo Håkan Sandbring

Cantargia presents new human data further supporting CAN10

March 18, 2024

Cantargia has reported new data …

Alexandra Ekman Ryding

Atrogi announces Phase 1a/b data

March 14, 2024

Atrogi has announced the full …

SynAct Pharma announces outcomes of independent audit

March 11, 2024

In November 2023 SynAct Pharma …

Affibody’s partner ACELYRIN announces positive results

March 11, 2024

ACELYRIN has announced that the …

Ultimovacs lab

Ultimovacs announces results from INITIUM study

March 7, 2024

The combined treatment of UV1 …

Nikolaj Sørensen

Orexo and Sobi to advance feasibility study

February 12, 2024

Orexo and Swedish Orphan Biovitrum …

Jamal El-Mosleh

Elicera receives approval to initiate clinical Phase I/II-study

February 9, 2024

Elicera Therapeutics has received approval …

Scandion Oncology announces Phase IIa data

January 31, 2024

The company has reported positive …

Alzinova announces phase 1b data

January 31, 2024

The company has announced the …

Søren Bregenholt

Alligator Bioscience announces positive Phase 2 results

January 29, 2024

The company has reported results …

DexTech Medical announces positive study results

January 24, 2024

The first test results from …

Toleranzia completes GLP toxicology study

January 16, 2024

Toleranzia has announced that the …

Mats Hansen

Spago Nanomedical reports positive Phase IIa data

December 20, 2023

The analysis of data from …

1
2
3
4
···
51